Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesIgG rheumatoid factor in early rheumatoid arthritis as a predictor of radiological changes and disease activity
Modern Rheumatology, 06/17/09
Nakamura H et al. – Study concludes that the IgG rheumatoid factor (IgG RF) index in early rheumatoid arthritis (RA) could be a prognostic factor in radiographic changes and disease activity 2-3 years after the initial visit.
Methods- Aim was to confirm whether IgG RF assessed in early RA could be a prognostic factor of disease activity and articular destruction
- IgG RF index was assessed in 46 pts; disease duration <1 yr
- Damage score (DS), carpal height ratio (CHR), clinical variables, and conventional RF values were evaluated at the initial visit and 2-3 yrs after the initial visit
- Incidence of IgG RF was 23.9% at the initial visit
- Pts with positive IgG RF showed higher DS and higher Lansbury’s index in the final observation
- They also showed a greater increase of DS and a greater decrease of CHR
- IgG RF index correlated with the final DS and final Lansbury’s index
Related Articles
Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjogren's syndrome
Journal of Rheumatology, 10/19/09
Relevance Score: 77%
The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha in human rheumatoid arthritis fibroblast-like synoviocyte
Rheumatology International, 10/30/09
Relevance Score: 68%
Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In Rheumatoid Arthritis Patients, Study Finds
ScienceDaily, 10/30/09
Relevance Score: 67%
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
Arthritis Research & Therapy, 10/20/09
Relevance Score: 67%
Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics
Modern Rheumatology, 10/08/09
Relevance Score: 67%
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiographic Measures to Assess Patients with Rheumatoid Arthritis: Advantages and Limitations
Rheumatic Disease Clinics of North America, 12/11/09
The morbid anatomy of "erosive osteoarthritis" of the interphalangeal finger joints. an optimized scoring system to monitor disease progression in affected joints
Annals of Rheumatic Diseases, 12/11/09
A case of eosinophilic orbital myositis associated with CSS
Modern Rheumatology, 12/11/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
A new graph and scoring system simplified analysis of changing states: disease remissions in a rheumatoid arthritis clinical trial
Journal of Clinical Epidemiology, 12/11/09
Criterion Contamination of Depression Scales in Patients with Rheumatoid Arthritis: The Need for Interpretation of Patient Questionnaires (as All Clinical Measures) in the Context of All Information About the Patient
Rheumatic Disease Clinics of North America, 12/11/09
RAPID3, an Index to Assess and Monitor Patients with Rheumatoid Arthritis, Without Formal Joint Counts: Similar Results to DAS28 and CDAI in Clinical Trials and Clinical Care
Rheumatic Disease Clinics of North America, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor